The world's latest public small eye < > confounded

New Post Public Reply Private Reply Replies (0) Message Board

Oct 17, 2017 at 4:20 PM 190

The world's latest public
small eye < >
confounded dumbass:

Dan Brown Declares That ‘God Cannot Survive Science’

This ignorant schlop
cannot picture there being a "Person"
or that existence is being 'led/pulled'
and that life is a direct expression of
something special.

Dan Brown, author of the best-selling Da Vinci Code, has joined philologist Friedrich Nietzsche in announcing the death of God, declaring that “God cannot survive science.”
“Historically, no god has survived science. Gods evolved,” the American writer said last week at the Frankfurt Book Fair, where he launched the German edition of his latest novel, Origin. “All the gods of our past have fallen. So the question now is: Are we naive to think the gods of today won’t suffer the same fate?”

“Our need for the exterior God that sits up there and judges us… will diminish and eventually disappear,” Brown said.

Along with several other modern God-slayers, such as Richard Dawkins, Sam Harris and Christopher Hitchens, Brown paints an absolute opposition between God and science, such that only one of the two can survive. Thus, as science advances, it will necessarily take the place of God—a thesis that not all accept.

“It is an extremely simplistic view of history to say that science kills religion,” said astrophysicist Jean-Pierre Luminet, research director of the French National Centre for Scientific Research (CNRS), who self-identifies as an atheist materialist.

According to Luminet, the notion of faith in a revealed truth or a personal God escapes the laws of the scientist busy decoding the universe. “From this point of view, each one refers to his own spiritual experience: for some, more science leads to God while others move away from it.”

Brown’s belief in the innate antagonism between religion and science bears out recent studies showing that nonbelievers tend to see the two fields to be irreconcilable.

A 2015 study by the Pew Center found that atheists are far more likely to see a conflict between faith and science than religious believers. While people of faith often see no conflict between science and religion, irreligious people often imagine that the two are completely incompatible.

The Pew report revealed that 73 percent of those who seldom or never attend religious services say that science and religion are often in conflict, while those who attend services at least once a week are 23 percent less likely to say so.

Among the unaffiliated—a group that includes atheists, agnostics, and those who belong to no religion in particular—the numbers are even higher. More than three quarters (76 percent) of the unaffiliated say that science and religion are “often in conflict.”

For many religious believers, however, the two fields are mutually supportive.

“It is absurd that one can still think of the relationship between science and faith in terms of opposition after more than a century of fruitful dialogue,” said Father Thierry Magnin, priest, physicist and rector of the Catholic University of Lyon. “God is not destined to fill the gaping holes left by science. As for the latter, scientists know well that it does not say everything.”

Brown’s knowledge of the Christian faith seems somewhat rudimentary, evidenced by his recent statement that “Christianity, Judaism and Islam share a gospel, and it’s the one I grew up with,” but this hasn’t curbed his enthusiasm for scandalizing believers.

In this fifth installment of the saga begun with the Da Vinci Code, Harvard professor Robert Langdon endeavors to decipher the mysteries of the origin of the world, exploring in particular the struggle between science and religion.

A former student of Langdon’s, Edmond Kirsch, has been assassinated just as he is about to reveal a scientific breakthrough that he says will bring about the downfall of Western religion and revolutionize how people think of life and death.

Brown’s claims that no religion has ever survived science have little backing in the historical record, since the modern natural sciences grew out of Judeo-Christian culture. As sociologist Rodney Stark has so convincingly shown, science was “still-born” in the great civilizations of the ancient world, and only came to fruition in Christian civilization.

Why is it, Stark ponders, that empirical science and the scientific method did not develop in China (with its sophisticated society), in India (with its philosophical schools), in Arabia (with its advanced mathematics), in Japan (with its dedicated craftsmen and technologies), or even in ancient Greece or Rome?

Science flourished in societies where a Judeo-Christian mindset understood nature to be ordered and intelligible, the work of an intelligent Creator, Stark concludes. Science grew and thrived where people assumed that the natural world makes sense and thus can be studied and understood. Far from being an obstacle to science, Christian soil provided the fertile humus where modern science could take root.

Unsurprisingly, some of history’s greatest scientists—Newton, Pasteur, Galilei, Lavoisier, Kepler, Copernicus, Faraday, Maxwell, Bernard, and Heisenberg—were Christians who found that faith was an asset, rather than an obstacle, to science.

Three years ago, Pope Francis asserted his conviction that science and faith are not only compatible, they need one another.

The Big Bang “doesn’t contradict the intervention of a divine Creator, but demands it,” the Pope said, because the origin of the world “is not the work of chaos.”

Addressing the plenary assembly of the Pontifical Academy of Sciences, Francis said that God is not some sort of wizard, but rather “the Creator who brought all things into being.” The origin of the world derives directly “from a supreme Principle of creative love,” he added.

“Evolution in nature is not inconsistent with the notion of creation, because evolution requires the creation of beings that evolve,” he said.

Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Ris-Rez May Set New Standard in Relapsed SCLC

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

GORGIE Unleashes Berry Burst: Target's New Drink Star

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

PwC US and India Unite for Global Consultancy Powerhouse

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Surfing Dogs Ride Waves, Support Orphan Pets

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

MRI Surveillance Gains Ground in Lung Cancer Care

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

UWM Faces Class Action Deadline: Key Insights for Investors

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Tam-Peli Steps Up in SCLC Battle: Trial Insights

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Trial Disappointment: No Significant Gains in NSCLC

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...